[HTML][HTML] New therapies for advanced thyroid cancer

D Laha, N Nilubol, M Boufraqech - Frontiers in endocrinology, 2020 - frontiersin.org
… subtype of thyroid cancer, most thyroid cancer-related deaths … these patients with advanced
thyroid cancer shows the lack … strategies that showed response in advanced thyroid cancer. …

… and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment

DC Shonka Jr, A Ho, AV Chintakuntlawar… - Head & …, 2022 - Wiley Online Library
… of advanced thyroid cancer in the literature. We propose a series of considerations that should
define advanced thyroid cancer … interrogation and targeted systemic treatment (Table 2). …

Lenvatinib as first-line treatment for advanced thyroid cancer: long progression-free survival

S De Leo, M Di Stefano, L Persani, L Fugazzola… - Endocrine, 2021 - Springer
… Differentiated thyroid cancer has an excellent prognosis. … RAI-refractory thyroid cancer and
in whom a local treatment is not … on advanced thyroid cancer patients treated with lenvatinib …

Progress in treating advanced thyroid cancers in the era of targeted therapy

CC Lubitz, PM Sadow, GH Daniels, LJ Wirth - Thyroid, 2021 - liebertpub.com
… with advanced thyroid cancer in need of systemic treatment (Fig… treatment in multiple tumor
types, and we find this to be an efficient upfront test for most cases of advanced thyroid cancer

[HTML][HTML] Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era

J Capdevila, A Awada, D Führer-Sakel… - Cancer Treatment …, 2022 - Elsevier
… genetic alterations in thyroid cancer that have the potential … treatments for thyroid cancers,
including the use of immune checkpoint inhibitors, and new generations of targeted treatments

Thyroid cancer, recent advances in diagnosis and therapy

F Nabhan, PH Dedhia… - … journal of cancer, 2021 - Wiley Online Library
… Follicular cell-derived forms of thyroid cancer account for ~95% of cases and will be termed
thyroid cancer for the purposes of this review. Thyroid cancer incidence has risen since the …

Real-world use of systemic therapies for the treatment of advanced thyroid cancers

DW Chen, M Banerjee, T Xu, FP Worden, MR Haymart - Endocrine Practice, 2023 - Elsevier
… observe temporal patterns in the treatment of advanced thyroid cancer. In addition, we
examined the contemporary treatment of advanced thyroid cancer between 2017 and 2021 based …

[HTML][HTML] ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

S Filetti, C Durante, DM Hartl, S Leboulleux, LD Locati… - Annals of …, 2022 - Elsevier
… updates for treating patients with advanced/metastatic DTCs, anaplastic thyroid cancers (ATCs)
and MTCs as given in the ESMO Clinical Practice Guideline (CPG) on thyroid cancer (TC…

Hypocalcemia during lenvatinib treatment for advanced thyroid cancer: clinical features and management in a real-life setting

S De Leo, M Trevisan, C Colombo, C Moneta… - Thyroid, 2023 - liebertpub.com
Background: Several toxicities are recorded during treatment of advanced thyroid cancer (TC)
with antiangiogenic drugs, including lenvatinib (LEN). Hypocalcemia was reported in …

Immunotherapy for advanced thyroid cancers—rationale, current advances and future strategies

JD French - Nature Reviews Endocrinology, 2020 - nature.com
… response in thyroid cancers is discussed. … treatment models of advanced thyroid cancer
are outlined, and the future of immunotherapeutic approaches for patients with thyroid cancer is …